A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer
暂无分享，去创建一个
M. O'Donnell | B. Chakraborty | R. Sood | B. Khamar | Rashmi K. Patel | S. Singh | A. Kundu | R. Modi | S. Bhatia | N. Desai | Ketan Shukla | Kapil Vachhani | J. Amlani | H. Krishnamoorthy | Chandreshwar Shukla | N. Mohanty | Chandreshwar P. Shukla